Канада - французский - Health Canada

amgen canada inc - trastuzumab - poudre pour solution - 150mg - trastuzumab 150mg - antineoplastic agents

Канада - французский - Health Canada

hoffmann-la roche limited - trastuzumab emtansine - poudre pour solution - 100mg - trastuzumab emtansine 100mg - antineoplastic agents

Канада - французский - Health Canada

hoffmann-la roche limited - trastuzumab emtansine - poudre pour solution - 160mg - trastuzumab emtansine 160mg - antineoplastic agents

Канада - французский - Health Canada

hoffmann-la roche limited - trastuzumab - solution - 600mg - trastuzumab 600mg - antineoplastic agents

Канада - французский - Health Canada

astrazeneca canada inc - trastuzumab déruxtécan - poudre pour solution - 100mg - trastuzumab déruxtécan 100mg - antineoplastic agents

Европейский союз - французский - EMA (European Medicines Agency)

roche registration gmbh - pertuzumab, trastuzumab - néoplasmes du sein - agents antinéoplasiques - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.

Канада - французский - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 40mg; 80mg - trastuzumab 40mg; pertuzumab 80mg - antineoplastic agents

Канада - французский - Health Canada

hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents

Камерун - французский - DPML (Direction de la Pharmacie du Médicament et des Laboratoires)

mylan pharmaceuticals private limited - le trastuzumab - poudre lyophilisée pour solution pour perfusion - 150mg

Канада - французский - Health Canada

hoffmann-la roche limited - pertuzumab; trastuzumab - solution - 420mg; 440mg - pertuzumab 420mg; trastuzumab 440mg - antineoplastic agents